Ovarian Tumors
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| First-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers. (NCT04711161) | Green3Bio, Inc. | 2020-12-21 |
| International Ovarian Tumour Analysis (IOTA) Phase 5 (NCT01698632) | KU Leuven | 2012-01-01 |
| French Observatory of Rare Malignant Tumors of the Ovary (NCT01304043) | ARCAGY/ GINECO GROUP | 2002-01-01 |
Track Ovarian Tumors automatically
Every clearance here is in the API, with alerts when new ones post.